Tau and amyloid positron emission tomography imaging predict driving performance among older adults with and without preclinical Alzheimer’s disease

Manuscript Number: 

17-0521R1

Author(s): 
Beau M. Ances, Ganesh M. Babulal, Tammie LS Benzinger, David B. Carr, Brian A. Gordon, Shruti Mishra, John C. Morris, Brian R. Ott, Catherine M. Roe, Sarah H. Stout

Disclosures

Beau M. Ances

  • Nothing to Disclose

Ganesh M. Babulal

  • Nothing to Disclose

Tammie LS Benzinger

  • Patents/Royalties
    Avid Radiopharmaceuticals provided the precursor and technology transfer support for the production of [18]F-AV1451 (flortaucipir). Avid Radiopharmaceuticals provided the doses of [18]F-AV-45 (florbetapir) and, along with the NIH, partially funded the acquisition of these scans.
    Grants
    • Agency: 
      Eli Lilly
      Dates: 
      2013-present
    • Agency: 
      Avid Radiopharmaceuticals
      Dates: 
      2010-present

David B. Carr

  • Consulting Fees:
    Paid Consulting Relationships: MedScape Traffic Injury Research Foundation AAAFTS American Geriatric Society University of Toronto
    Grants
    • Agency: 
      NIA
      Dates: 
      2004-Present
    • Agency: 
      NIE
      Dates: 
      2016-Present
    • Agency: 
      Missouri Department of Transportation
      Dates: 
      2006-Present
    • Agency: 
      The Rehabilitation Institute of St. Louis
      Dates: 
      2015-2017
    • Agency: 
      State Farm Insurance
      Dates: 
      2014-2015

Brian A. Gordon

  • Nothing to Disclose

Shruti Mishra

  • Nothing to Disclose

John C. Morris

  • Consulting Fees:
    Lilly USA consultant
    Grants
    • Agency: 
      National Institute of Health

Brian R. Ott

  • Consulting Fees:
    Amgen: consulting/clinical trial steering committee Accera: consulting/DSMB
    Grants
    • Agency: 
      Eli Lilly
      Dates: 
      current
    • Agency: 
      Merck
      Dates: 
      current
    • Agency: 
      Janssen
      Dates: 
      current
    • Agency: 
      Biogen
      Dates: 
      current
    • Agency: 
      AbbVie
      Dates: 
      current
    • Agency: 
      Long Term Care Group
      Dates: 
      current

Catherine M. Roe

  • Nothing to Disclose

Sarah H. Stout

  • Nothing to Disclose